Back to the library
Hormonal research
Bremelanotide
Human trialsResearch education only. This profile does not establish benefits or safety for personal use.
EvidenceHuman trials
Curated studies1
Research areaHormonal research
At a glance
Also known as PT-141. Human trials studied a specific sexual desire disorder in premenopausal women.
How it is studied
A melanocortin receptor agonist. Findings from RECONNECT apply to the studied indication and population.
Evidence & studies 1 curated
Read the population, methods, and limitations alongside each outcome. This selection is a starting point, not a systematic review.
Human randomized trial · 2019Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
Read summary & limitationsRisks & limits
- Clinical benefit and long-term safety are not established by the evidence curated here.
- Identity, purity, formulation, and route affect risk; a research label is not evidence of suitability for human use.
No universal storage, reconstitution, or administration protocol is provided. Product-specific instructions and evidence must be established separately.